Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Synonyms :
Class :
100
mg
Orally 
once a day
Maximum dose: 400mg/day
Dose Adjustments
Renal dose adjustments
Contraindicated for use in moderate to severe renal failure with CrCl< 50 mL/mL
Hepatic dose adjustments
Contraindicated
When lumiracoxib is used together with bufexamac, this leads to enhanced risk or seriousness of adverse outcomes
the rate of excretion of abacavir may be decreased
the rate of metabolism of abrocitinib is reduced
the hypertensive activity of acebutolol may be reduced
the risk of adverse effects may be increased
the risk of bleeding can be increased
the protein binding efficiency of acetohexamide may be reduced
the risk of hypertension, hyperkalemia, or renal failure may be increased
the risk of gastrointestinal bleeding may be increased
the risk of gastrointestinal irritation may be increased
the risk of hyperkalemia may be increased
the risk of hyperkalemia may be increased
the risk of gastrointestinal bleeding may be increased
the therapeutic activity of trichlormethiazide may be reduced
lumiracoxib leads to a reduction in the rate of excretion of nitric oxide, which leads to an increased level of serum
When lumiracoxib is used together with nifenazone, this leads to enhanced risk or seriousness of adverse events
When lumiracoxib is used together with diazoxide, this leads to reduction in therapeutic effectiveness of diazoxide